The question is really how long will it be before enough AVZ holders will take the price they are likely to offer of 3 or 4 times current SP tops.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025